1.
Letter from Barrios and Escobar regarding article, "trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: the national...
by Barrios, Vivencio
Circulation, 18 June 2013, Vol.127(24), pp.e859
2.
The novel analogue of hirsutine as an anti-hypertension and vasodilatary agent both in vitro and in vivo.
by Zhu, Kai
PloS one, 2015, Vol.10(4), p.e0119477
3.
A Randomized, Double Blind, Placebo-Controlled, Multicenter Phase II Trial of Allisartan Isoproxil in Essential Hypertensive Population at Low-Medium Risk
by Li, Ying
PLoS One, Feb 2015, Vol.10(2), p.e0117560
4.
Antihypertensive drugs and statins should be considered in arterial stiffness evaluation in ethnic differences
by Varol, Ercan
International Journal of Cardiology, Oct 15, 2015, Vol.197, p.144
5.
SERS and MD simulation studies of a kinase inhibitor demonstrate the emergence of a potential drug discovery tool.(APPLIED PHYSICAL SCIENCES: BIOPHYSICS COMPUTATIONAL BIOLOGY)(surf...
by Karthigeyan, Dhanasekaran
Proceedings of the National Academy of Sciences of the United States, July 22, 2014, Vol.111(29), p.10416(6)
6.
Burning Mouth Syndrome Secondary to Antihypertensive Drug Use: Clinical Case Report
by De Sousa Lopes, Mariana Canuto Melo
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2015, Vol.120(2), pp.e58-e59
7.
8.
Meta-analysis: impact of drug class on adherence to antihypertensives.
by Kronish, Ian M
Circulation, April 19, 2011, Vol.123(15), pp.1611-1621
9.
Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data.
by National Library of Medicine
Lancet (London, England), August 16, 2014, Vol.384(9943), pp.591-598
10.
Dopamine receptor D₃ regulates endocytic sorting by a Prazosin-sensitive interaction with the coatomer COPI
by Zhang , Xin
2012
Proceedings of the National Academy of Sciences of the United States of America, 2012, Vol.109(31), pp.12485-12490
2012
11.
GW26-e1321 The Changing of Antihypertensive agents for elder in recent years
by Zhu, Ning
Journal of the American College of Cardiology, Oct 20, 2015, Vol.66(16), pp.C200-C201
12.
RIGOROUS CONTROL OF BLOOD PRESSURE IS JUSTIFIED IN OLDER PEOPLE WITH CHRONIC KIDNEY DISEASE.(Communications to the British Geriatrics Society Autumn Meeting 28th-30th November 2012...
by John, S. G.
Age and Ageing, March, 2013, Vol.42(2), p.S72(1)
13.
Hydrochlorothiazide as the Diuretic of Choice for Hypertension: Time to Kick the Habit
by Sternlicht, Hillel
Journal of the American College of Cardiology, 02 February 2016, Vol.67(4), pp.390-391
14.
Hypertension Prevalence, Cardiac Complications, and Antihypertensive Medication Use in Children.
by Dobson, Craig P
The Journal of pediatrics, July 2015, Vol.167(1), pp.92-7.e1
15.
Riociguat for the treatment of pulmonary arterial hypertension.(Report)
by Ghofrani, Hossein - Ardeschir
The New England Journal of Medicine, July 25, 2013, Vol.369(4), p.330(11)
16.
Prevalence and determinants of controlled hypertension in a German population cohort.
by van Den Berg, Neeltje
BMC public health, June 19, 2013, Vol.13, p.594
17.
Antihypertensive Agents and Risk of Parkinson's Disease: A Nationwide Cohort Study
by Yen-Chieh, Lee
PLoS One, Jun 2014, Vol.9(6), p.e98961
18.
Does the rising placebo response impact antihypertensive clinical trial outcomes? An analysis of data from the Food and Drug Administration 1990-2016.
by Khan, Arif
PloS one, 2018, Vol.13(2), p.e0193043
19.
Commonly used antihypertensives and lower urinary tract symptoms: results from the Boston Area Community Health (BACH) Survey
by Hall, Susan A.
BJU International, June 2012, Vol.109(11), pp.1676-1684
20.
Capsule commentary on Johnson et al., Antihypertensive medication initiation among young adults with regular primary care use
by Gupta, Ankur
Journal of general internal medicine, May 2014, Vol.29(5), pp.785
